Supporting evidence
High-intensity interval exercise × HbA1c
- Authoritative support
- 5
- Available studies
- 5
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
HIIT and Aerobic-Resistance Training Improve Diabetes Outcomes
Rct
- Comparison
- Participants engaged in a 12 week intervention that included an individualised combined aerobic and resistance exercise training program along with standard hospital care. · Participants underwent a HIIT program adapted for safety and physical capacity, involving structured interval sessions. · The control group received standard hospital care without a structured exercise program.
- Duration / follow-up
- 12 weeks
Relevant effects
Mean difference
3.33
Mean difference
3.35
Study 2 · Included
HIIT Improves Glucose Control in Diabetic Neuropathy Patients
Rct
- Comparison
- Participants engaged in a 12 week high intensity interval training program. · Participants engaged in a 12 week moderate intensity continuous training program. · Participants maintained their usual daily activities and received health education.
- Duration / follow-up
- 24 weeks
Relevant effects
Mean difference
1.11 · 0.001
Mean difference
0.81 · 0.001
Study 3 · Included
HIIT improves glycaemic control and pancreatic function in T2D patients
Rct
- Comparison
- T2D patients undergoing HIIT to assess effects on glycaemic control and pancreatic function. · Healthy individuals matched for age, height, and weight to T2D patients.
- Duration / follow-up
- 35 weeks
Relevant effect
Mean difference
0.5 · 0.04
Study 4 · Limited
Interval walking training may improve physical fitness in type 2 diabetes
- Comparison
- Participants performed interval walking training for 20 weeks.
- Duration / follow-up
- 20 weeks
Study 5 · Included
Low-volume HIIT improves glycaemic control in type 2 diabetes
Rct
- Comparison
- Participants engaged in 8 weeks of supervised c hiit training. · Participants engaged in 8 weeks of supervised c mict training. · Participants continued with usual care for 8 weeks before being re randomised.
- Duration / follow-up
- 52 weeks
Relevant effects
Mean difference
0.7 · 0.014
Mean difference
1.2 · 0.001
